Navigation Links
InspireMD Reports Results For Period Ending Sept. 30, 2012
Date:11/2/2012

TEL AVIV, Israel, November 2, 2012 /PRNewswire/ --

InspireMD, Inc. ("InspireMD" or the "Company") (OTC: NSPR) announced financial results for the period ended September 30, 2012, the first quarter of its 2013 fiscal year.

As previously indicated, revenue declined from the same period in 2011 due mainly to stocking and selling disruptions caused by a realignment of the Company's distributors in advance of the presentation of the MASTER trial of its MGuard™ Embolic Protective Stent (EPS) at the 24th Annual Transcathter Therapeutics (TCT) scientific meeting in Miami on October 24.

The positive results, presented at the TCT's Late Breaking Clinical Trials Session by Study Chairman Gregg W. Stone, MD, showed that the novel MGuard EPS provided a statistically and clinically significant acute advantage and, as a result, may hold the potential to lower the incidence of adverse sequela and prolong survival of heart attack victims.

MGuard EPS is CE Mark approved. It is not approved for sale in the U.S. by the Food and Drug Administration (FDA) at this time. The Company plans to initiate a FDA approval study on or before March 31, 2013.

Key financial highlights 1Q ended September 30, 2012 include:

--Revenue for the period ended September 30, 2012 totaled $509,000, compared to $1,986,000 in the same period in 2011, a decrease of $1,477,000, or 74.4 percent, due largely to anticipated disruptions in stocking and sales activities in the periods leading up to the TCT.

--Gross profit for the Sept. 30 2012 period was $279,000, compared to $1,185,000 for the Sept. 30, 2011 period, a decline of 76.5 percent.

--Total operating expenses for the Sept. 30, 2012 period were $3,560,000, compared to $3,335,000 in the Sept. 30, 2011 period. A $274,000 decrease in G&A in the Sept. 30, 2012 period was offset by a $399,000 increase in R&D (mainly to support the MAST
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. InspireMD Announces First Quarter 2012 Financial Results
2. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
3. InspireMD to Present at Inaugural Marcum Microcap Conference on June 20th in New York
4. InspireMD to Present at Harvard Investors Group on June 27 in New York
5. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
6. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
7. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
8. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
9. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
10. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
11. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 2015  Daktari Diagnostics was honored at the 2015 ... Service of Society Award. IEEE President and CEO, Howard ... presented the award to Principal Scientist Martina Medkova ... Saturday, June 20, 2015, at the historic Waldorf Astoria hotel ... "I have spent more than 3 years as a ...
(Date:6/29/2015)... , June 29, 2015  New guidelines ... American Stroke Association give hope for better outcomes ... experience an acute ischemic stroke each year. Stryker,s ... key products used in the clinical trials that ... new AHA/ASA guidelines strongly recommend endovascular therapy with ...
(Date:6/29/2015)... , June 29, 2015  PDL BioPharma, Inc. ... entered into a credit agreement with CareView Communications, Inc. ... to $40 million of secured debt financing. CareView is ... on patient care monitoring. Under the credit ... million of debt financing in two tranches of $20 ...
Breaking Medicine Technology:Daktari Honored with IEEE Spectrum Award 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 2PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 4
... Athera Biotechnologies AB and Dyax,Corp. (NASDAQ: ... entered into a,collaboration to discover and to ... of cardiovascular inflammatory diseases., The collaboration ... Athera,scientific founders, Professors Frostegard and de Faire ...
... Amylin,s integrated neurohormonal ... approach to obesity pharmacotherapy, SAN DIEGO, Oct. 1 ... data for its pipeline obesity,candidates will be presented at the ... 3-7. The Obesity Society,s annual,meeting is one of the largest ...
Cached Medicine Technology:Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 2Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 3Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 4Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 2Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 3Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 4Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 5Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 6Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 7
(Date:6/29/2015)... ... June 29, 2015 , ... Healthpointe, ... surgeon, Dr. John A. Mitamura, MD., PhD into their world-class multidisciplinary team of ... including Long Beach , Irwindale and La Tijera-Los Angeles. , Orthopedic ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... within the weekend edition of USA TODAY. This 12-page, glossy, full-color special section ... Today in highly targeted markets totaling approximately 450,000 copies, with an estimated readership ...
(Date:6/29/2015)... , ... June 29, 2015 , ... ... now being offered at NewYork-Presbyterian/Weill Cornell Medical Center. The device is the first ... an alternative to continuous positive airway pressure (CPAP), the current standard of care ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... the independent auditor of customer service for the 40-center nursing home group. Sixteen ... skilled nursing centers in the United States in one or more customer service ...
(Date:6/29/2015)... Delaware (PRWEB) , ... June 29, 2015 , ... With ... Master® announces a partnership with the American Board of Urgent Care Medicine and the ... PRA Category 1 Creditâ„¢ to Urgent Care physicians and health care professionals. , According ...
Breaking Medicine News(10 mins):Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 2Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 3Health News:Mediaplanet partners with USA TODAY and Kris Letang to raise awareness about the risk of heart attack and stroke 2Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 2Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 3Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 4Health News:National HealthCare Centers Receive 'Customer Experience Awards' 2Health News:National HealthCare Centers Receive 'Customer Experience Awards' 3Health News:National HealthCare Centers Receive 'Customer Experience Awards' 4Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 2Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 3
... Intelligent Order Routing allows hospital pharmacies to design their ... , , ROSEMONT, Ill., June 15 ... Inc., (Nasdaq: OMCL ) a leading provider ... the Omnicell WorkflowRx (TM) 6.0 central ...
... UTRECHT, The Netherlands, June 15 The largest global,study ... that strongly connected people have more enjoyment in their ... but more successful. Strongly,connected people have a better idea ... achieve it. The study, carried out by &intoconnection, proves ...
... HILLS, Mass., June 15 Joseph F. Finn, Jr., C.P.A. ("Finn") ... to and blocks the effects of galectin-3. Galectin-3 plays an ... proliferation and tumor metastasis, which is the spread of cancer beyond ... have multiple benefits in combating cancer cells, including: , , ...
... software platform and internal support for DailyMed Pharmacy , ... debt , , INDIANAPOLIS, June 15 Arcadia Resources, ... of home care, medical staffing, and pharmacy services under the ... retail pharmacy management software business. , , Arcadia ...
... and Media , , PHILADELPHIA, June 15 , , ... assistance and international healthcare, and provider of pandemic, ... companies, around the globe:, ... outbreak and, pandemic specialist, ...
... ... of 2009 "Best in KLAS" vendors , ... Orem, UT (PRWEB) June 15, 2009 -- Healthcare research firm ... in seven key market categories - including computed tomography (CT), digital mammography, smart pumps ...
Cached Medicine News:Health News:Omnicell Boosts Pharmacy Efficiency with Enhanced WorkflowRx(TM) Central Pharmacy Automation Software 2Health News:Omnicell Boosts Pharmacy Efficiency with Enhanced WorkflowRx(TM) Central Pharmacy Automation Software 3Health News:Scientific Study Makes it Possible to Measure Connection Between People 2Health News:Scientific Study Makes it Possible to Measure Connection Between People 3Health News:Prospect Therapeutics' In Vitro Studies Demonstrate that GCS-100 Drug Binds to and Blocks the Effects of Galectin-3 2Health News:Arcadia Resources Sells Non-Core Software Business 2Health News:Arcadia Resources Sells Non-Core Software Business 3Health News:Doctor, Pandemic Planning Expert to Host Webinar on Influenza H1N1 2Health News:Doctor, Pandemic Planning Expert to Host Webinar on Influenza H1N1 3Health News:Doctor, Pandemic Planning Expert to Host Webinar on Influenza H1N1 4Health News:Top-Performing Medical Equipment Companies Announced 2
Our 2.5v Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
3.5v Ophthalmic Diagnostic Set with AutoStep Coaxial Ophthalmoscope, Spot Retinoscope, Rechargeable Handle, and Soft Case. High-quality eyecare from the preferred name in diagnostic instruments....
... are standard in all Welch Allyn ... students, the 18335-SDS combines the superior ... the superior illumination of the Halogen ... of the Finnoff Transilluminator, and the ...
High-quality eyecare from the preferred name in diagnostic instruments....
Medicine Products: